126 related articles for article (PubMed ID: 2250573)
1. Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism.
Graham WC; Robertson RG; Sambrook MA; Crossman AR
Life Sci; 1990; 47(18):PL91-7. PubMed ID: 2250573
[TBL] [Abstract][Full Text] [Related]
2. Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey.
Crossman AR; Peggs D; Boyce S; Luquin MR; Sambrook MA
Neuropharmacology; 1989 Nov; 28(11):1271-3. PubMed ID: 2687716
[TBL] [Abstract][Full Text] [Related]
3. Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate.
Brotchie JM; Mitchell IJ; Sambrook MA; Crossman AR
Mov Disord; 1991; 6(2):133-8. PubMed ID: 1647492
[TBL] [Abstract][Full Text] [Related]
4. Dyskinesia in the primate following injection of an excitatory amino acid antagonist into the medial segment of the globus pallidus.
Robertson RG; Farmery SM; Sambrook MA; Crossman AR
Brain Res; 1989 Jan; 476(2):317-22. PubMed ID: 2539224
[TBL] [Abstract][Full Text] [Related]
5. The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism.
Wichmann T; Bergman H; DeLong MR
J Neurophysiol; 1994 Aug; 72(2):521-30. PubMed ID: 7983516
[TBL] [Abstract][Full Text] [Related]
6. MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates.
Zuddas A; Oberto G; Vaglini F; Fascetti F; Fornai F; Corsini GU
J Neurochem; 1992 Aug; 59(2):733-9. PubMed ID: 1629743
[TBL] [Abstract][Full Text] [Related]
7. Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease.
Goldberg JA; Boraud T; Maraton S; Haber SN; Vaadia E; Bergman H
J Neurosci; 2002 Jun; 22(11):4639-53. PubMed ID: 12040070
[TBL] [Abstract][Full Text] [Related]
8. Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey.
Page RD; Sambrook MA; Crossman AR
Neuroscience; 1993 Jul; 55(1):147-65. PubMed ID: 7688878
[TBL] [Abstract][Full Text] [Related]
9. The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography.
Robertson RG; Clarke CA; Boyce S; Sambrook MA; Crossman AR
Brain Res; 1990 Oct; 531(1-2):95-104. PubMed ID: 2289139
[TBL] [Abstract][Full Text] [Related]
10. Further investigations into the pathophysiology of MPTP-induced parkinsonism in the primate: an intracerebral microdialysis study of gamma-aminobutyric acid in the lateral segment of the globus pallidus.
Robertson RG; Graham WC; Sambrook MA; Crossman AR
Brain Res; 1991 Nov; 563(1-2):278-80. PubMed ID: 1786541
[TBL] [Abstract][Full Text] [Related]
11. Alteration of pallidal cholinergic activity in MPTP-treated monkeys: effect of dihydro-alpha-ergocryptine (DEK).
Curti D; Izzo E; Benzi G
Neurosci Lett; 1994 Feb; 168(1-2):213-6. PubMed ID: 8028778
[TBL] [Abstract][Full Text] [Related]
12. Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced parkinsonism in the monkey: relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake.
Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR
Neurosci Lett; 1986 Jan; 63(1):61-5. PubMed ID: 3485267
[TBL] [Abstract][Full Text] [Related]
13. Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey.
Crossman AR; Mitchell IJ; Sambrook MA
Neuropharmacology; 1985 Jun; 24(6):587-91. PubMed ID: 3875056
[TBL] [Abstract][Full Text] [Related]
14. Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism.
Heimer G; Bar-Gad I; Goldberg JA; Bergman H
J Neurosci; 2002 Sep; 22(18):7850-5. PubMed ID: 12223537
[TBL] [Abstract][Full Text] [Related]
15. Developing a stable bilateral model of parkinsonism in rhesus monkeys.
Smith RD; Zhang Z; Kurlan R; McDermott M; Gash DM
Neuroscience; 1993 Jan; 52(1):7-16. PubMed ID: 8433810
[TBL] [Abstract][Full Text] [Related]
16. Neurons in the globus pallidus do not show correlated activity in the normal monkey, but phase-locked oscillations appear in the MPTP model of parkinsonism.
Nini A; Feingold A; Slovin H; Bergman H
J Neurophysiol; 1995 Oct; 74(4):1800-5. PubMed ID: 8989416
[TBL] [Abstract][Full Text] [Related]
17. Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of parkinsonism.
Gomez-Mancilla B; Boucher R; Bédard PJ
Mov Disord; 1992; 7(1):43-7. PubMed ID: 1348351
[TBL] [Abstract][Full Text] [Related]
18. MPTP-Induced pallidal lesions in rhesus monkeys.
Zhang Z; Zhang M; Ai Y; Avison C; Gash DM
Exp Neurol; 1999 Jan; 155(1):140-9. PubMed ID: 9918713
[TBL] [Abstract][Full Text] [Related]
19. Glutamic acid decarboxylase mRNA expression in medial and lateral pallidal neurons in the MPTP-treated monkey and patients with Parkinson's disease.
Herrero MT; Levy R; Ruberg M; Javoy-Agid F; Luquin MR; Agid Y; Hirsch EC; Obeso JA
Adv Neurol; 1996; 69():209-16. PubMed ID: 8615130
[No Abstract] [Full Text] [Related]
20. Relative sparing of the dopaminergic innervation of the globus pallidus in monkeys made hemi-parkinsonian by intracarotid MPTP infusion.
Schneider JS; Dacko S
Brain Res; 1991 Aug; 556(2):292-6. PubMed ID: 1682010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
